Mark Knapp
- Pathology and Forensic Medicine top 5%
- Oncology
- Genetics top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Co-authors
- André GoyJutta K. NeuenburgSven de VosDarrin M. BeaupreJerry PingDipti Patel‐DonnellyJia RuanDavid Morgan
- Topics
- Lymphoma Diagnosis and Treatment (11 papers)Chronic Lymphocytic Leukemia Research (8 papers)Lung Cancer Treatments and Mutations (6 papers)
- Partner nations
- United StatesChinaSaudi Arabia
In The Last Decade
Mark Knapp
20 papers receiving 391 citations
Peers
Comparison fields: 5 of 39
- Pathology and Forensic Medicine 255
- Oncology 226
- Genetics 143
- Molecular Biology 92
- Pulmonary and Respiratory Medicine 70
Countries citing papers authored by Mark Knapp
This map shows the geographic impact of Mark Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Knapp more than expected).
Fields of papers citing papers by Mark Knapp
This network shows the impact of papers produced by Mark Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Knapp. The network helps show where Mark Knapp may publish in the future.
Co-authorship network of co-authors of Mark Knapp
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Knapp. A scholar is included among the top collaborators of Mark Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Knapp. Mark Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 58 | |
| 3 | 88 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 7 | |
| 7 | 7 | |
| 8 | 23 | |
| 9 | 4 | |
| 10 | 12 | |
| 11 | 10 | |
| 12 | 74 | |
| 13 | 21 | |
| 14 | 3 | |
| 15 | 10 | |
| 16 | 3 | |
| 17 | 16 | |
| 18 | 2 | |
| 19 | 2 | |
| 20 | 23 |
About Mark Knapp
Mark Knapp is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 20 papers that have together received 395 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (255 citations), Genetics (143 citations) and Oncology (226 citations). Mark Knapp has collaborated with scholars based in United States, China and Saudi Arabia. Frequent co-authors include André Goy, Jutta K. Neuenburg, Sven de Vos, Darrin M. Beaupre, Jerry Ping, Dipti Patel‐Donnelly, Jia Ruan, David Morgan, Robert J. Belt and Maria Delioukina. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.